Что на самом деле обнаружили испытания GLP-1

Никаких «до» и «после», никаких влиятельных лиц. Только рандомизированные испытания, размеры эффектов и то, что маркетинг оставляет за кадром — каждое утверждение связано с его записью в PubMed.

66peer-reviewed citations
42European languages
0sponsored verdicts
Ручка для инъекций, прижатая к кожному порту на предплечье.
Marius Vassnes · CC BY-SA 4.0 · Wikimedia Commons

Start here

Each page answers one question and shows its working. If you only read one, read the page on stopping — it is the finding that changes how you should think about the whole class.

Mechanism

How GLP-1 drugs actually work

Slower gastric emptying, hypothalamic satiety signalling, and why "it just makes you eat less" is both true and incomplete.

Body composition

How much of the loss is muscle?

Roughly a quarter to a third of the weight lost is lean mass. Whether that matters is a harder question.

Durability

What happens when you stop

Most of the weight comes back within a year. This is the single most important finding in the field.

Outcomes

Does it protect your heart?

SELECT found a 20% reduction in major cardiovascular events — in a population that was not diabetic.

Pipeline

The oral pills

Oral semaglutide and orforglipron: same class, no needle, slightly smaller effect.

Связанные материалы

Fasting Evidence

Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.

Metabolism Review

Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.

Weight Loss Evidence

Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.

Sleep Evidence

Sleep, circadian rhythm and the wearables that claim to measure both.

Эта страница была автоматически переведена с английского. Цитаты и числа остались без изменений. Читайте оригинал на английском, если что-то звучит странно. Читать оригинал на английском